DoubleLine ETF Adviser’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,760
Closed -$263K – 211
2026
Q2
$263K Sell
3,760
-466
-11% -$24.1K 0.11% 153
2026
Q1
$215K Buy
+4,226
New +$197K 0.08% 167

Other funds holding MRNA

DoubleLine ETF Adviser's MRNA Position: Q3 2026 in Review

DoubleLine ETF Adviser sold out of Moderna (MRNA) in Q3 2026, closing a stake of 3,760 shares — an estimated $263K sold.

DoubleLine ETF Adviser first reported a position in MRNA in Q1 2026 and held it in 2 quarters. The position peaked at $263K in Q2 2026. 1,033 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • DoubleLine ETF Adviser reported no remaining Moderna position as of Q3 2026 after selling out during the quarter.
  • DoubleLine ETF Adviser sold 3,760 Moderna shares in Q3 2026, an estimated $263K.
  • DoubleLine ETF Adviser first reported a position in Moderna in Q1 2026 and held it in 2 quarters.
  • DoubleLine ETF Adviser's Moderna position peaked at $263K in Q2 2026.
  • 1,033 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q3 2026, filed 13 Nov 2026.